无阿片与含阿片丙泊酚麻醉用于甲状腺及甲状旁腺手术的比较:一项随机对照试验
该随机双盲对照试验在成人甲状腺及甲状旁腺手术患者中比较无阿片(艾司氯胺酮、利多卡因、右美托咪定和丙泊酚)与含阿片(舒芬太尼和丙泊酚)丙泊酚麻醉,主要结局为术后48小时内恶心呕吐发生率。结果显示无阿片组发生率5%显著低于含阿片组24%(OR 0.17,95%CI 0.08-0.35,P<0.001),需治疗人数为5.3,并减少补救止吐药需求、拔管后低血压和去饱和发生率,提高患者满意度,但拔管时间稍延长。
要点
- 无阿片丙泊酚麻醉可显著降低甲状腺及甲状旁腺手术后48小时恶心呕吐发生率。
- 无阿片组补救止吐药需求、拔管后低血压和去饱和发生率更低,患者满意度更高。
- 两组术后疼痛评分和30天结局相似,但无阿片组拔管时间稍延长。
核心结论
- 无阿片丙泊酚麻醉可降低甲状腺及甲状旁腺手术患者术后48小时内恶心呕吐发生率。
- 无阿片麻醉方案可优化甲状腺及甲状旁腺手术的麻醉管理。
研究设计与样本
- 随机、双盲、对照试验,在中国大陆两个医疗中心进行。
- 成人择期甲状腺及甲状旁腺手术患者按1:1随机分组,按性别和试验中心分层。
- 无阿片组使用艾司氯胺酮、利多卡因、右美托咪定和丙泊酚;含阿片组使用舒芬太尼和丙泊酚。
- 丙泊酚输注滴定至脑电双频指数45-55。
- 所有患者使用地塞米松和昂丹司琼预防恶心呕吐,并使用对乙酰氨基酚和氟比洛芬酯多模式镇痛。
主要发现
- 术后48小时内恶心呕吐发生率无阿片组为5%(10/197),含阿片组为24%(47/197)。
- OR(95%CI)为0.17(0.08-0.35),P<0.001,需治疗人数为5.3。
- 无阿片组补救止吐药需求减少,拔管后低血压和去饱和发生率降低,患者满意度更高。
- 无阿片组拔管时间稍延长。
- 两组术后疼痛评分和30天结局相似。
临床怎么用
- 对于甲状腺及甲状旁腺手术患者,可考虑采用无阿片丙泊酚麻醉方案以降低术后恶心呕吐发生率。
- 无阿片方案可减少补救止吐药需求及拔管后低血压和去饱和,但需注意拔管时间可能稍延长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative nausea and vomiting occur frequently following thyroid and parathyroid surgery and are associated with worse patient outcomes. We hypothesised that opioid-free propofol anaesthesia would reduce the incidence of postoperative nausea and vomiting compared with opioid-inclusive propofol anaesthesia in patients undergoing these procedures. METHODS: We conducted a randomised, double-blinded controlled trial in adult patients scheduled to undergo thyroid and parathyroid surgery at two medical centres in mainland China. Patients were allocated randomly (1:1, stratified by sex and trial site) to an opioid-free anaesthesia group (esketamine, lidocaine, dexmedetomidine and propofol) or an opioid-inclusive group (sufentanil and propofol). Propofol infusions were titrated to bispectral index 45-55. Patients received prophylaxis for nausea and vomiting using dexamethasone and ondansetron and multimodal analgesia with paracetamol and flurbiprofen axetil. The primary outcome was the incidence of postoperative nausea and vomiting in the first 48 h after surgery. RESULTS: We assessed 557 patients for eligibility and 394 completed this trial. The incidence of postoperative nausea and vomiting in the first postoperative 48 h was lower in the opioid-free anaesthesia group (10/197, 5%) compared with opioid-inclusive group (47/197, 24%) (OR (95%CI) 0.17 (0.08-0.35), p < 0.001), yielding a number needed to treat of 5.3. Additionally, opioid-free propofol anaesthesia was associated with a reduced need for rescue anti-emetics, lower rates of hypotension and desaturation after tracheal extubation, and higher patient satisfaction. Time to tracheal extubation was prolonged slightly in the opioid-free group. The two groups had similar postoperative pain scores and 30-day outcomes. DISCUSSION: Opioid-free propofol anaesthesia reduced postoperative nausea and vomiting in patients undergoing thyroid and parathyroid surgery. An opioid-free anaesthetic regimen can optimise anaesthetic care during thyroid and parathyroid surgery.
引用
- Wang D, Sun Y, Zhu YJ, et al. Comparison of opioid-free and opioid-inclusive propofol anaesthesia for thyroid and parathyroid surgery: a randomised controlled trial. Anaesthesia. 2024. PMID: 39037325. doi:10.1111/anae.16382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。